Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Revance (United States)
Homepage:
revance.com
Alternate names:
Revance,
Revance Therapeutics,
Revance Therapeutics, Inc.
ROR:
024v32s64
OpenAlex ID:
I4405271252
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations
2020
·
Shannon M. Smith
, Robert H. Dworkin
, et al.
·
Pain
·
208
Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices
2016
·
Jean Carruthers
, Cheryl Burgess
, et al.
·
Dermatologic Surgery
·
133
Myocarditis and Heart Failure Associated With Hepatitis C Virus Infection
2006
·
Akira Matsumori
, Toshio Shimada
, et al.
·
Journal of Cardiac Failure
·
122
Acne Scar Treatment: A Multimodality Approach Tailored to Scar Type
2016
·
Lisa A. Zaleski-Larsen
, Sabrina G. Fabi
, et al.
·
Dermatologic Surgery
·
104
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
2021
·
Nowell Solish
, Jean Carruthers
, et al.
·
Drugs
·
87
PDF
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
2019
·
Jean D. Carruthers
, Steve Fagien
, et al.
·
Plastic & Reconstructive Surgery
·
78
An Overview of Methods of Extraction, Isolation and Characterization of Natural Medicinal Plant Products in Improved Traditional Medicine Research
2020
·
Dobgima John Fonmboh
, Ejoh Richard Abah
, et al.
·
Asian Journal of Research in Medical and Pharmaceutical Sciences
·
71
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)
2019
·
Vince Bertucci
, Nowell Solish
, et al.
·
Journal of the American Academy of Dermatology
·
71
Efficacy and Safety Evaluation of a Novel Botulinum Toxin Topical Gel for the Treatment of Moderate to Severe Lateral Canthal Lines
2010
·
FREDRIC BRANDT
, CHRISTOPHER O'CONNELL
, et al.
·
Dermatologic Surgery
·
68
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo
2017
·
Jean Carruthers
, Nowell Solish
, et al.
·
Dermatologic Surgery
·
62
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study
2018
·
Joseph Jankovic
, Daniel Truong
, et al.
·
Movement Disorders Clinical Practice
·
59
PDF
Characterization of diffusion and duration of action of a new botulinum toxin type A formulation
2011
·
Hongran F. Stone
, Zhao Zhu
, et al.
·
Toxicon
·
54
Real-World Experience With VMAT2 Inhibitors
2019
·
Nicki Niemann
, Joseph Jankovic
·
Clinical Neuropharmacology
·
52
Increasing the level of resistant starch in ‘Presidio’ rice through multiplex CRISPR–Cas9 gene editing of starch branching enzyme genes
2022
·
Sudip Biswas
, Oneida Ibarra
, et al.
·
The Plant Genome
·
49
PDF
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
2020
·
Sabrina G. Fabi
, Joel L. Cohen
, et al.
·
Dermatologic Surgery
·
39
Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro
2024
·
Jimmy Faivre
, Kevin Wu
, et al.
·
Aesthetic Surgery Journal
·
34
PDF
The Potential Pharmacological and Medicinal Properties of Neem (Azadirachta indica A. Juss) in the Drug Development of Phytomedicine
2019
·
E. A. Tembe-Fokunang
, Fokunang Charles
, et al.
·
Journal of Complementary and Alternative Medical Research
·
33
A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study
2020
·
Jeremy B. Green
, Kavita Mariwalla
, et al.
·
Dermatologic Surgery
·
31
PDF
Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial
2017
·
Christina Marciniak
, Peter McAllister
, et al.
·
PM&R
·
31
PDF
Safety and Efficacy of RT002, an Injectable Botulinum Toxin Type A, for Treating Glabellar Lines: Results of a Phase 1/2, Open-Label, Sequential Dose-Escalation Study
2014
·
Enrique Garcia-Murray
, María Luisa Velasco Villasenor
, et al.
·
Dermatologic Surgery
·
29
Development and Validation of a New Clinically-Meaningful Rating Scale for Measuring Lateral Canthal Line Severity
2012
·
Michael A. Kane
, Andrew Blitzer
, et al.
·
Aesthetic Surgery Journal
·
22
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
2023
·
Conor J. Gallagher
, Ronald R. Bowsher
, et al.
·
Toxins
·
18
PDF
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product
2023
·
Steven F. Dowdy
, Conor J. Gallagher
, et al.
·
Expert Opinion on Drug Delivery
·
16
Pharmacovigilance of Natural Herbal Medicines Research for Efficacy, Safety and Quality Assurance of Phytomedicine Products
2020
·
Estella Tembe Fokunang
, Dobgima John Fonmboh
, et al.
·
Journal of Complementary and Alternative Medical Research
·
16
A study of the relationship between mechanical and ultrasonic properties of dystrophic and normal skeletal muscle
1995
·
B. Hete
, K.K. Shung
·
Ultrasound in Medicine & Biology
·
16
Show more works
View as search
Works count:
122
Citation count:
6,155
Year
Topic
Type
